Labcorp — Jul 24, 2025 release

• Added digital pathology capabilities in Central Labs, including advanced image scanning to preserve critical sample data and AI-powered solutions to provide analysis on large datasets instantly. On July 10, 2025, the company announced a quarterly cash dividend of $0.72 per share of common stock, payable on September 11, 2025, to stockholders of record at the close of business on August 28, 2025. In the quarter, Labcorp repurchased $200 million of common stock. Additionally, Labcorp raised 2025 guidance for enterprise revenue, adjusted EPS and free cash flow primarily driven by currency, as well as the underlying strength of its businesses. 2 LABCORP HOLDINGS INC. AND SUBSIDIARIES CONSOLIDATED RESULTS Three Months Ended June 30, Six Months Ended June 30, 2025 2024 Delta 2025 2024 Delta Revenue Summary (Dollars in billions) Total Revenue $ 3.53  $ 3.22  9.5  % $ 6.87  $ 6.40  7.4  % Organic (1) 5.4  % 3.7  % Acquisitions, net of Divestitures 3.5  % 3.6  % Foreign Exchange 0.6  % 0.1  % (1) Organic revenue is no longer broken out between the Base Business and COVID-19 Testing. Earnings Summary (Dollars in millions, except per share data) Operating Income (“OI”) $ 394.5  $ 294.8  $ 720.5  $ 616.1  OI as % of Revenue 11.2  % 9.2  % 200 bps 10.5  % 9.6  % 90 bps Adjustments (2) $ 137.1  $ 185.1  $ 280.1  $ 316.6  Adjusted Operating Income (“AOI”) (3) $ 531.6  (4) $ 479.9  $ 1,000.6  $ 932.7  AOI as % of Revenue 15.1  % (5) 14.9  % 20 bps 14.6  % 14.6  % — bps N